Sponsor or institution

Clinical trials and research at Telix Pharmaceuticals (Innovations) Pty Limited

• 7Clinical trials
• 10Countries

Newest trials

All recruiting trials (7)

• Samarium-153 treatment optimized for longer-lasting relief of end-stage cancer bone pain

  This trial will test a samarium-153 radioligand injection to see if it reduces severe bone pain in adults with advanced cancer and painful bone metastases.

  Recruiting at 6 sites Phase 1 Telix Pharmaceuticals (Innovations) Pty Limited · Miami, Florida and 5 other locations · NCT07197645

• 177Lu-TLX250 for advanced relapsed or recurrent clear-cell kidney cancer

  This will test whether 177Lu-TLX250, a CAIX-targeting radioligand, helps adults with CAIX-positive advanced or relapsed clear-cell kidney cancer who have had 2–3 prior therapies.

  Recruiting Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited · Sydney, New South Wales and 4 other locations · NCT07197580

• TLX101-Tx plus standard care versus standard care alone for recurrent glioblastoma

  This test checks whether adding TLX101-Tx, a tumor-targeted radiopharmaceutical given with lomustine, helps adults with first-recurrence glioblastoma control their tumor or live longer compared with lomustine alone.

  Recruiting at 7 sites Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited · Gold Coast, Queensland and 8 other locations · NCT07100730

• 89Zr-TLX250 for imaging clear cell kidney cancer

  This study is testing a new imaging agent called 89Zr-TLX250 to see if it can help find clear cell kidney cancer in adults who have uncertain kidney masses before they have surgery.

  Recruiting Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited · Beijing and 7 other locations · NCT06750419

• Imaging soft tissue sarcoma using a radioactive version of olaratumab

  This study is testing a new radioactive version of a drug called olaratumab to see if it can help doctors better spot soft tissue sarcoma tumors in patients.

  Recruiting at 2 sites Phase 1 Telix Pharmaceuticals (Innovations) Pty Limited · Brisbane, Queensland and 2 other locations · NCT06537596

• Evaluating 177Lu-TLX591 with standard care for advanced prostate cancer

  This study is testing if adding a new treatment called 177Lu-TLX591 to standard care can help men with advanced prostate cancer who haven't responded to other treatments live longer without their cancer getting worse.

  Recruiting at 22 sites Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited · Orange, California and 32 other locations · NCT06520345

• Combining two treatments for patients with certain solid tumors

  This study is testing if combining a radioactive treatment with another drug can help people with certain solid tumors, like advanced kidney cancer, feel better and improve their condition.

  Recruiting at 5 sites Phase 1 Telix Pharmaceuticals (Innovations) Pty Limited · North Ryde, New South Wales and 4 other locations · NCT05868174

Quick answers

How many clinical trials run by Telix Pharmaceuticals (Innovations) Pty Limited are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in Australia (5 trials), United States (2 trials), Canada (1 trial), New Zealand (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →